rss
BMJ Case Reports 2017; doi:10.1136/bcr-2017-220509
  • Rare disease
  • CASE REPORT

Rheumatoid arthritis causing diffuse alveolar haemorrhage: a novel therapeutic approach

  1. Sonye Danoff3
  1. 1Department of Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA
  2. 2Department of Critical Care Medical, National Institutes of Health, Bethesda, Maryland, USA
  3. 3Division of Pulmonary and Critical Care, Johns Hopkins Medicine, Baltimore, Maryland, USA
  1. Correspondence to Dr Panagis Galiatsatos, panagis.galiatsatos{at}nih.gov
  • Accepted 30 May 2017
  • Published 14 June 2017

Summary

Pulmonary vascular involvement due to rheumatoid arthritis, presenting as diffuse alveolar haemorrhage (DAH), is a rare phenomenon, especially if there are no signs of systemic vasculitides. Furthermore, how to proceed with the management of these patients is challenging, as in the case of our patient, who had recurrent DAH. We present a case of a patient with known rheumatoid arthritis who had recurrence of DAH that spanned over several years, often presenting with life-threatening respiratory failure. While her DAH presentation improved with high-dose glucocorticoids, to resolve her recurrence, we opted to initiate treatment with rituximab, with a short course of azathioprine. After the second round of rituximab, the patient continues to do well without any further DAH-related complications. We also summarise prior cases of such patients to highlight variable treatment options.

Footnotes

  • Contributors AO and PG both prepared the manuscript and cared for the patient. SB and SD both cared for the patient and oversaw the completion of the manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article